VitaNova Life Sciences (VNOV) Cash from Financing Activities (2017 - 2025)
VitaNova Life Sciences (VNOV) reported Cash from Financing Activities of -$101500.0 for Q2 2025, down 320.55% on a YoY basis from $46021.1 in Q2 2024, and down 283.02% quarter-over-quarter from -$26500.0 in Q1 2025.
VitaNova Life Sciences (VNOV) Cash from Financing Activities (2017 - 2025) Analysis & Trends
VitaNova Life Sciences has reported Cash from Financing Activities for 8 years, with the latest figure at -$101500.0 in Q2 2025.
- For the quarter ending Q2 2025, Cash from Financing Activities fell 320.55% year-over-year to -$101500.0; the trailing twelve-month figure through Jan 2026 stood at -$101500.0 (down 236.49% YoY), and the FY2025 full-year result was -$3000.0, down 100.31% from the prior year.
- Cash from Financing Activities for Q2 2025 stood at -$101500.0, down from -$26500.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $958913.0 in Q1 2024, with the low at -$101500.0 in Q2 2025.
- Historically, Cash from Financing Activities has averaged $82662.1 across 4 years, with a median of $9853.0 in 2021.
- Annual changes were most pronounced in 2024 — Cash from Financing Activities soared 23872.82% — and 2025, when it slumped 320.55%.
- VitaNova Life Sciences' Cash from Financing Activities stood at $12100.0 in 2021, then slumped by 33.96% to $7991.0 in 2023, then surged by 806.02% to $72400.0 in 2024, then slumped by 240.19% to -$101500.0 in 2025.
- The last three Cash from Financing Activities figures came in at -$101500.0 (Q2 2025), -$26500.0 (Q1 2025), and $72400.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -2.82 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 3.98 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -483.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 120.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 51.08 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -1.37 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 3.80 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 347,627.00 |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | -101,500.00 |
| Apr 30, 2025 | -101,500.00 |
| Jan 31, 2025 | -26,500.00 |
| Jan 31, 2025 | -26,500.00 |
| Oct 31, 2024 | 72,400.00 |
| Oct 31, 2024 | 72,400.00 |
| Jul 31, 2024 | 52,600.00 |
| Jul 31, 2024 | 52,600.00 |
| Apr 30, 2024 | -24,135.00 |
| Apr 30, 2024 | -24,135.00 |
| Jan 31, 2024 | 958,913.00 |
| Jan 31, 2024 | 958,913.00 |
| Oct 31, 2023 | 7,991.00 |
| Oct 31, 2023 | 7,991.00 |
| Jul 31, 2023 | 17,419.00 |
| Jul 31, 2023 | 17,419.00 |
| Jan 31, 2023 | 4,000.00 |
| Jan 31, 2023 | 4,000.00 |
| Oct 31, 2021 | 12,100.00 |
| Oct 31, 2021 | 12,100.00 |